PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Nitrofural→

Nitrofural PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
59-87-0
Molecular formula
C6H6N4O4
Molecular weight
198.14 g/mol
Drug class
Nitrofuran antibacterialtopical nitrofurazone antimicrobial
Mechanism of action
After enzymatic reduction of its nitro group in susceptible microorganisms, reactive intermediates damage bacterial DNA and other cellular macromolecules, inhibiting microbial growth.
Indications / reported uses
  • Topical treatment of susceptible superficial bacterial skin infections and infected burns or wounds in countries where nitrofurazone remains authorised; it is not a general systemic antibacterial indication

Sources: NLM MeSH — Nitrofurazone · PubMed — Nitrofurazone topical antibacterial · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Nitrofural PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Nitrofural Permitted Daily Exposure (PDE) report (the Nitrofural PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Nitrofural Occupational Exposure Limit (OEL) report (the Nitrofural OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.